Annaliese Franz and her lab are designing therapeutic molecules of the future. Through organic synthesis and catalysis, the team is building and improving molecules with therapeutic potential. Some current projects include developing a new nanoparticle technology for livestock vaccines and improving treatments for neurodegenerative disorders like epilepsy.
The University of California, Davis, is pleased to announce the autumn cohort of the Science Translation and Innovative Research (STAIR) Grant Program. The cohort includes Annaliese Franz, a professor in Department of Chemistry.
